Intramedullary infusion of sodium butyrate in uninephrectomized rats resulted in the reversal of angiotensin-II-induced glomerulosclerosis and decreased the expression of the (pro)renin receptor, angiotensinogen, renin, angiotensin-I-converting enzyme and renal inflammatory markers [40]. Here, ATP6AP2 is linked to glomerulosclerosis.